AYTU Aytu BioScience Inc

For the quarter ended 31/12/2022, Aytu BioScience Inc's revenues decreased by 4.98% and amounted to 26.28M. Net income decreased by 132.32% to -6.69M. Net assets decreased by 15.01% to 45.82M and EPS decreased from -0.06 to -43.04.